What is Fuse Medical, Inc. (FZMD)?

Fuse Medical, Inc. (FZMD) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of FZMD?

The current price of FZMD is $0.03. Prices are updated in real time on Stocks360.

What is FZMD's price-to-earnings (PE) ratio?

FZMD's trailing twelve-month PE ratio is 15.00, based on current price and earnings per share data available on Stocks360.

What is FZMD's market capitalization?

FZMD's market capitalization is $2,216,874.00, placing it in the small-cap tier.

Fuse Medical, Inc. (FZMD)

Stock analysis · OTC · Healthcare · Medical - Devices

$0.03

Market Cap

$2.22M

PE (TTM)

15.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.45

Day Range

$0.03 – $0.03

52-wk Range

$0.02 – $0.08

Avg Volume

N/A

Volume

109.32K

Fuse Medical, Inc. (FZMD) is a publicly traded company in the Healthcare sector. Latest price: $0.03. Market cap $2.22M. Trailing PE 15.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-29 · $0.08 2026-10-28 · $0.03 (-62.50%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Fuse Medical, Inc.

Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based manufacturer and supplier of medical device implants. Its product portfolio primarily encompasses a wide range of orthopedic implants. This includes specialized internal and external fixation devices for the foot and ankle, as well as plating systems and total joint reconstruction implants designed for upper and lower extremities. Additionally, Fuse Medical provides solutions for soft tissue fixation and augmentation, catering to sports medicine procedures. The company's offerings extend to comprehensive spinal implants, addressing indications such as trauma, degenerative disc disease, and various deformities. Beyond its orthopedic line, the company also supplies osteo-biologics and regenerative products. These encompass a variety of materials such as human allografts, tendons, synthetic skin, bone substitutes, and other regenerative tissues. Fuse Medical's client base includes hospitals, diverse medical facilities, and a network of sub-distributors.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	15.00×
P/S (TTM)	0.25×
P/B	0.31×
PEG	0.02×
P/FCF (TTM)	16.15×
EV / EBITDA	8.17×
EV / Sales	0.50×
Earnings Yield	6.49%
Free Cash Flow Yield	6.19%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$4.50M
Revenue (TTM)	$9.02M
Net Income (TTM)	$143.87K
Free Cash Flow (TTM)	-$136.16K
Net Debt	$2.28M
Working Capital	$4.77M
Gross Margin	71.95%
Operating Margin	4.25%
Net Margin	1.52%
Return on Equity	2.05%
Return on Invested Capital	3.75%